Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. The company provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. It offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was incorporated in 1998 and is based in Taipei, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.
Buy
Sell